No profile data available.
ProPhase Labs, Inc. (PRPH) is a healthcare company in the DNA testing equipment industry, based in Uniondale, United States, with about 19 full-time employees.
It reported revenue of $6.77 million for fiscal year 2024, down 84.7% from fiscal year 2023, and net income of -$53.36 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $1.01 million, down 18.9% from a year before. Its market capitalization was $155,925 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products.
ProPhase Labs reported $6.77 million in revenue for fiscal year 2024, down 84.7% from $44.38 million in fiscal year 2023. In Q2 2026 revenue was $1.01 million.
$155,925 as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Co-Diagnostics, Inc. (CODX), Cardio Diagnostics Holdings, Inc. (CDIO), Epigenomics AG N (EPGNF), Many Bright Ideas Technologies Inc. (MBGNF).